Our findings revealed a crucial role for BACH1 in regulating insulin signaling, suggesting that BACH1 may become a promising target for the treatment of metabolic disorders such as obesity and type 2 diabetes mellitus. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.